Organization | Dalhousie University

Dalhousie University Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Halifax Canada (1818)

Organization Overview

First Clinical Trial

1997

NCT00004422

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

Abraham Nunes | Britney Benoit | Canada East Spine Centre; Horizon Health Network Department of Orthopaedic Surgery; Dalhousie University Faculty of Medicine Department of Surgery | Canadian Center for Vaccinology, Dalhousie University | Capital District Health Authority and Dalhousie University | Capital District Health Authority/Dalhousie University | CDHA, Dalhousie University | CDHA/Dalhousie University | Dalhousie | Dalhousie Anesthesia | Dalhousie Medical Research Foundation | Dalhousie Ophthalmology and Visual Sciences Research Group | Dalhousie Univeristy - Canadian Center for Vaccinology | Dalhousie University | Dalhousie University and IWK Health Center | Dalhousie University, Canadian Center for Vaccinology | Dalhousie University/CIRN | Dalhousie University, Department of Medicine, Division Infectious Diseases | Dalhousie University, Halifax | Dalhousie University & IWK Health | Dalhousie University & IWK Health Centre | Dalhousie University, IWK Health Centre | Dalhousie University Medical School | Dalhousie University / Nova Scotia Health | Dalhousie University, Nova Scotia Health Authority | Dalhousie University/Nova Scotia Health Authority | Dalhousie University/QE II Health Sciences Centre, Halifax, NS | Dalhousie University/QEII HSC | David Young | Department of Medicine, Division of Infectious Diseases, Nova Scotia Health Authority, Dalhousie University | Horizon Health Network, Dalhousie University Department of Urology | Injury Free Nova Scotia (IFNS) | IWK Health Centre | IWK Health Centre and Dalhousie University | IWK Health Centre, Dalhousie University | Jessica Gray | Lalonde, Donald H., M.D. | Melissa Andrew | Michael Kucharczyk | New Brunswick Heart Centre | Nova Scotia Cancer Centre, Department of Radiation Oncology, Dalhousie University | Nova Scotia Health | Nova Scotia Health Authority/Dalhousie University | Queen Elizabeth II Health Sciences Centre. Dalhousie University | School of Nursing, Faculty of Health, Dalhousie University | Scott Halperin | Tadashi Watabe

Active Ingredients

Drugs in Phase 4 Trials (47)

23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)

4cmenb vaccine (1 trial)

albuterol (proventil) (1 trial)

amlodipine (norvasc) (1 trial)

arepanrix (2 trials)

atenolol (tenormin) (1 trial)

brexpiprazole (rexulti) (2 trials)

crm197 (1 trial)

dasabuvir (Exviera) (1 trial)

diphtheria-tetanus-acellular pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine (2 trials)

diphtheria toxoid (1 trial)

ephedrine (1 trial)

escitalopram (lexapro) (2 trials)

hepatitis a vaccine, inactivated (vaqta) (2 trials)

hydrochlorothiazide (esidrix) (1 trial)

hydromorphone (diladid) (1 trial)

imiquimod (aldara) (1 trial)

levobupivacaine (chirocaine) (2 trials)

levofloxacin (levaquin) (1 trial)

lidocaine (xylocaine) (1 trial)

menacwy conjugate vaccine (1 trial)

methadone (methadose) (1 trial)

morphine (4 trials)

mycophenolate (myfortic) (1 trial)

neisvac-c (1 trial)

ombitasvir (Viekira Pak) (1 trial)

oxygen (1 trial)

oxytocin (syntocinon) (1 trial)

paritaprevir (viekira pak) (1 trial)

phentolamine mesylate (regitine) (2 trials)

phenylephrine (Prefrin) (5 trials)

pneumococcal 13-valent conjugate vaccine (prevnar 13) (2 trials)

pregabalin (lyrica) (2 trials)

prostaglandin (1 trial)

quinapril (accupril) (1 trial)

ranitidine (zantac) (1 trial)

ribavirin (virazole) (1 trial)

ritonavir (Norvir) (2 trials)

ropivacaine (naropin) (2 trials)

serogroup b meningococcal vaccine (1 trial)

sodium chloride (4 trials)

tdap (3 trials)

terazosin (hytrin) (1 trial)

tetanus-diphtheria toxoid (1 trial)

tetanus toxoid (1 trial)

tetracaine (pontocaine) (1 trial)

urea (2 trials)

Drugs in Phase 3 Trials (28)

acetaminophen (tylenol) (2 trials)

acetylsalicylic acid (aspirin) (2 trials)

bromocriptine (parlodel) (1 trial)

codeine (Phenergan) (2 trials)

dinoprostone (prostin e2) (1 trial)

domperidone (2 trials)

fluoxetine (prozac) (2 trials)

human fecal microbiota (1 trial)

ibuprofen (motrin) (3 trials)

immune globulin (human) (1 trial)

infanrix (1 trial)

lactobacillus helveticus (1 trial)

lactobacillus rhamnosus (1 trial)

lithium (lithonate) (2 trials)

loperamide (imodium) (1 trial)

methylene blue (proveblue) (1 trial)

metronidazole (flagyl) (1 trial)

miglitol (glyset) (1 trial)

misoprostol (cytotec) (1 trial)

mupirocin (bactroban) (1 trial)

nerinetide (1 trial)

paroxetine (paxil) (1 trial)

polysaccharide iron complex (1 trial)

rivaroxaban (xarelto) (2 trials)

sucrose (3 trials)

tranexamic acid (cyklokapron) (1 trial)

vancomycin (Vancocin) (1 trial)

vitamin d3 (1 trial)

Drugs in Phase 2 Trials (16)

azd1222 (1 trial)

baricitinib (olumiant) (1 trial)

bnt162b2 (1 trial)

cannabis (1 trial)

deferoxamine (desferal) (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

inactivated influenza vaccine (2 trials)

leuprolide (lupron) (1 trial)

lisdexamfetamine (vyvanse) (1 trial)

lopinavir (Kaletra) (1 trial)

maraviroc (selzentry) (1 trial)

mrna-1273 (1 trial)

sarilumab (kevzara) (1 trial)

vinblastine (velban) (1 trial)

Drugs in Phase 1 Trials (12)

bordetella pertussis d420 (1 trial)

bpsc-1001 vaccine (1 trial)

capsaicin (qutenza) (1 trial)

covigen (1 trial)

dabigatran (pradaxa) (1 trial)

dpx-rsv(a) (1 trial)

hepatitis b vaccine (recombinant) (recombivax) (1 trial)

human papillomavirus 9-valent vaccine, recombinant (Gardasil 9) (1 trial)

potassium alum (1 trial)

sodium bicarbonate (1 trial)

streptanova (1 trial)

vbi-1501 (1 trial)

Drugs in Other Trials (10)

beclomethasone (vanceril) (1 trial)

blueberry allergenic extract (1 trial)

caffeine (1 trial)

epinephrine (levophed) (1 trial)

haloperidol (haldol) (1 trial)

methotrexate (1 trial)

metoclopramide (reglan) (1 trial)

olanzapine (zyprexa) (1 trial)

onabotulinumtoxinA (Botox) (1 trial)

ondansetron (zofran) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Acute Pain (Phase 3)

Aneurysm (Phase 4)

Aneurysm, Dissecting (Phase 4)

Apnea (Phase 4)

Atrial Fibrillation (Phase 4)

Bipolar Disorder (Phase 3)

Blood Coagulation Disorders (Phase 1)

Brain Diseases (Phase 2)

Brain Infarction (Phase 2)

Brain Ischemia (Phase 3)

Breast Diseases (Phase 3)

Bulimia (Phase 2)

Bulimia Nervosa (Phase 2)

Central Nervous System Diseases (Phase 2)

Cerebral Hemorrhage (Phase 2)

Cerebral Infarction (Phase 3)

Cerebrovascular Disorders (Phase 2)

Clostridium Infections (Phase 3)

Cognitive Dysfunction (Phase 3)

Communicable Diseases (Phase 4)

Coronavirus Infections (Phase 2)

Craniocerebral Trauma (Phase 2)

Cytomegalovirus Infections (Phase 1)

Depression (Phase 3)

Depressive Disorder (Phase 3)

Depressive Disorder, Major (Phase 3)

Disease (Phase 3)

Dyspnea (Phase 3)

Emergencies (Phase 3)

Fatigue (Phase 3)

Gastroenteritis (Phase 3)

Glaucoma (Phase 4)

Glioma (Phase 2)

Hemorrhage (Phase 2)

Hemorrhagic Fever, Ebola (Phase 2)

Hemostatic Disorders (Phase 1)

Hepatitis C (Phase 4)

Hypotension (Phase 4)

Infarction (Phase 2)

Infections (Phase 4)

Influenza, Human (Phase 4)

Insulin Resistance (Phase 3)

Ischemia (Phase 3)

Leukemia (Phase 4)

Leukemia, Lymphoid (Phase 4)

Lung Diseases (Phase 3)

Lung Diseases, Obstructive (Phase 3)

Meningococcal Infections (Phase 4)

Multiple Myeloma (Phase 3)

Neoplasms, Plasma Cell (Phase 3)

Nervous System Diseases (Phase 2)

Neuralgia (Phase 4)

Osteoarthritis (Phase 2)

Osteoarthritis, Knee (Phase 2)

Pain, Postoperative (Phase 4)

Pneumococcal Infections (Phase 3)

Pneumonia (Phase 3)

Polycystic Ovary Syndrome (Phase 3)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 4)

Premature Birth (Phase 2)

Prostatic Neoplasms (Phase 2)

Pulmonary Disease, Chronic Obstructive (Phase 3)

Rhinitis (Phase 1)

Rotator Cuff Injuries (Phase 4)

Shock (Phase 4)

Stroke (Phase 2)

Subarachnoid Hemorrhage (Phase 2)

Suicide (Phase 3)

Surgical Wound Infection (Phase 3)

Thromboembolism (Phase 3)

Tuberculosis (Phase 3)

Tuberculosis, Pulmonary (Phase 3)

Urinary Bladder Neoplasms (Phase 3)

Uterine Inertia (Phase 4)

Vascular Diseases (Phase 2)

Venous Thromboembolism (Phase 3)

Virus Diseases (Phase 4)

Whooping Cough (Phase 4)

Wounds and Injuries (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 101
# of Trial APIs: 113